Purdue University Center for Cancer Research
Altername Author Names

       
Members sometimes have altername names under which their publications are listed in PubMed. To find these alternate names, choose a member and view the list of possible other names from publications we downloaded from others. It is comparing based on last name only.

Existing names associated with this member:
IDPubMed NameFirst Name 
929Das CChittaranjanX

Possible alternate names of this member used in PubMed:
Alternate PubMed NameFirst NameAffiliationTitlePMIDDate 
Das S SoumyajitDepartment of Industrial and Molecular Pharmaceutics, Purdue University, West Lafayette, IN 47907, USA.Afamitresgene autoleucel: first cell therapy for synovial sarcoma.401552395/21/2025Associate
Das S SubhadeepDepartment of Biochemistry, Purdue University, BCHM A343, 175 S. University Street, West Lafayette, IN 47907-2063, USA.Supinoxin blocks small cell lung cancer progression by inhibiting mitochondrial respiration through DDX5.402240045/21/2025Associate
Das D DebanandaExperimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection.328200055/8/2025Associate
Das D DebanandaHIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, 20892, MD, United States.Single atom changes in newly synthesized HIV protease inhibitors reveal structural basis for extreme affinity, high genetic barrier, and adaptation to the HIV protease plasticity.326063785/8/2025Associate
Das R RhijuDepartment of Biochemistry, Stanford University School of Medicine, USA.RNA-Puzzles Round IV: 3D structure predictions of four ribozymes and two aptamers.323714555/8/2025Associate
Udaskin ML Molly LPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada, M5G 1L7.The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors.347253615/8/2025Associate
Barradas-Bautista D DidierKing Abdullah University of Science and Technology, Thuwal, Saudi Arabia.Prediction of protein assemblies, the next frontier: The CASP14-CAPRI experiment.344534655/8/2025Associate
Das D DebanandaExperimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication.335101335/8/2025Associate
Kordasti S ShahramCRUK-KHP Centre, Comprehensive Cancer Centre, King's College London, London, UK.SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation.338278975/8/2025Associate
Castro-Caldas M MargaridaUniversidade de Lisboa, Faculty of Pharmacy, Research Institute for Medicines (iMed.ULisboa), Lisboa, Portugal.Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 .336347515/8/2025Associate
Cavadas C ClaudiaUniversity of Coimbra, Portugal, CNC - Center for Neuroscience and Cell Biology & Faculty of Pharmacy, Coimbra, Portugal.Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 .336347515/8/2025Associate
Dagdas Y YasinGregor Mendel Institute, Vienna Biocenter, Vienna, Austria.Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 .336347515/8/2025Associate
Das H HiranmoyTexas Tech University Health Sciences Center, Department of Pharmaceutical Sciences, Amarillo, TX, USA.Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 .336347515/8/2025Associate
Dasarathy S SrinivasanCleveland Clinic, Department of Gastroenterology, Hepatology and Nutrition, Cleveland, OH, USA.Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 .336347515/8/2025Associate
Dasari SK Santosh KMD Anderson Cancer Center, Department of Gynecologic Oncology and Reproductive Medicine, Houston, TX, USA.Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 .336347515/8/2025Associate
Dash S SrikantaTulane University Health Sciences Center, Department of Pathology and Laboratory Medicine, New Orleans, LA, USA.Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 .336347515/8/2025Associate
Posadas EM Edwin MDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis.351155565/8/2025Associate
Thulasidas JS Jeya ShreeDepartment of Electrical Engineering, Divison of High Voltage Engineering, Anna University, Guindy, India.High-throughput, Label-free Proteomics Identifies Salient Proteins and Genes in MDA-MB-231 Cells Treated with Natural Neem-based Electrochemotherapy.349937685/8/2025Associate
Jesudason CD Cynthia DLgenia Fortville Indiana USA.SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late-onset Alzheimer's disease.380236225/8/2025Associate
Kandasamy M MurugeshIndiana University School of Medicine Indianapolis Indiana USA.SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late-onset Alzheimer's disease.380236225/8/2025Associate
Barradas-Bautista D DidierKing Abdullah University of Science and Technology (KAUST), Saudi Arabia.Impact of AlphaFold on structure prediction of protein complexes: The CASP15-CAPRI experiment.379059715/8/2025Associate
Das S SubhadeepDepartment of Biochemistry, Purdue University, BCHM A343, 175 S. University Street, West Lafayette, IN 47907-2063, USA.The genomic region of the 3' untranslated region (3'UTR) of PHO84, rather than the antisense RNA, promotes gene repression.374620735/8/2025Associate
Das D DebanandaExperimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.GRL-142 binds to and impairs HIV-1 integrase nuclear localization signal and potently suppresses highly INSTI-resistant HIV-1 variants.374369825/8/2025Associate
Barradas-Bautista D DidierKaust Visualization Lab, Core lab Division, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.Discriminating physiological from non-physiological interfaces in structures of protein complexes: A community-wide study.373659365/8/2025Associate
Swamydas M MuthulekhaFungal Pathogenesis Section, Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases, NIH, Bethesda, MD, USA.C5a-licensed phagocytes drive sterilizing immunity during systemic fungal infection.372207465/8/2025Associate
Thulasidas JS Jeya ShreeDepartment of sEEE, College of Engineering, Division of High Voltage Engineering, Anna University, Chennai, Tamil Nadu, India.Efficacy of electrical pulse mediated tomato lipophilic extract on human breast cancer cell.371479905/8/2025Associate
Anandasothy K KartikanDepartment of Biochemistry, Purdue University, West Lafayette, IN, United States.Cdc14 phosphatase contributes to cell wall integrity and pathogenesis in Candida albicans .368760655/8/2025Associate
Das S SaswatiCOVID-19 International Research Team, Medford, MA, USA.sChemNET: a deep learning framework for predicting small molecules targeting microRNA function.394434445/8/2025Associate
Das S SubhamSchool of Mechanical Engineering, Purdue University, 585 Purdue Mall, West Lafayette, IN, 47907, USA.Effects of nanoparticle deformability on multiscale biotransport.392227955/8/2025Associate
Das S SubhadeepDepartment of Biochemistry, Purdue University, West Lafayette, Indiana, USA.Novel insights on the positive correlation between sense and antisense pairs on gene expression.390872535/8/2025Associate
Kadastik M MNational Institute of Chemical Physics and Biophysics, Tallinn, Estonia.Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.389963255/8/2025Associate
Daskalakis G GInstitute of Nuclear and Particle Physics (INPP), NCSR Demokritos, Aghia Paraskevi, Greece.Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.389963255/8/2025Associate
Foudas C CUniversity of Ioánnina, Ioánnina, Greece.Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.389963255/8/2025Associate
Das AK A KNational Institute of Science Education and Research, An OCC of Homi Bhabha National Institute, Bhubaneswar, Odisha, India.Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.389963255/8/2025Associate
Das I IImperial College, London, United Kingdom.Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.389963255/8/2025Associate
Chudasama R RThe University of Alabama, Tuscaloosa, Alabama, USA.Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.389963255/8/2025Associate
Das A AUniversity of Notre Dame, Notre Dame, Indiana, USA.Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.389963255/8/2025Associate
Das P PPrinceton University, Princeton, New Jersey, USA.Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.389963255/8/2025Associate
Das S SPurdue University, West Lafayette, Indiana, USA.Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.389963255/8/2025Associate
Dasu S SUniversity of Wisconsin-Madison, Madison, Wisconsin, USA.Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.389963255/8/2025Associate
Yuldashev BS B SAn institute or international laboratory covered by a cooperation agreement with CERN.Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.389963255/8/2025Associate
Das SJ S JPhysics Department, Brookhaven National Laboratory, Upton, New York, USA.Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.389963255/8/2025Associate
Gurdasani SS S SPhysikalisches Institut, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.389963255/8/2025Associate
Kordas K KDepartment of Physics, Aristotle University of Thessaloniki, Thessaloniki, Greece.Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.389963255/8/2025Associate
Psallidas A ANational Centre for Scientific Research "Demokritos", Agia Paraskevi, Greece.Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.389963255/8/2025Associate
Tsigaridas S STRIUMF, Vancouver, British Columbia, Canada.Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.389963255/8/2025Associate
Ramdas B BaskarDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA.Alkynyl nicotinamides show antileukemic activity in drug-resistant acute myeloid leukemia.389503305/8/2025Associate
Das S SoumyajitDepartment of Industrial and Molecular Pharmaceutics, Purdue University, West Lafayette, Indiana 47907, United States.Human Natural Killer Cells Cryopreserved without DMSO Sustain Robust Effector Responses.382306665/8/2025Associate
Das S SayoniResearch Department of Structural and Molecular Biology, University College London, London, United Kingdom.The CAFA challenge reports improved protein function prediction and new functional annotations for hundreds of genes through experimental screens.317445469/16/2024Associate
Barradas-Bautista D DidierPhysical Sciences and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.Blind prediction of homo- and hetero-protein complexes: The CASP13-CAPRI experiment.316125679/16/2024Associate
Das D DebanandaExperimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.Novel Protease Inhibitors Containing C-5-Modified bis -Tetrahydrofuranylurethane and Aminobenzothiazole as P2 and P2' Ligands That Exert Potent Antiviral Activity against Highly Multidrug-Resistant HIV-1 with a High Genetic Barrier against the Emergence of Drug Resistance.310855209/16/2024Associate
Das D DebanandaExperimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 20892-1868, USA.Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1s.308861669/16/2024Associate
Kadasala NR Naveen R Rapid Uptake and Photodynamic Inactivation of Staphylococci by Ga(III)-Protoporphyrin IX.301759179/16/2024Associate
Kordasti S ShahramComprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.Human retinoic acid-regulated CD161 + regulatory T cells support wound repair in intestinal mucosa.303973509/16/2024Associate
Floudas C ChristodoulosTAn analysis and evaluation of the WeFold collaborative for protein structure prediction and its pipelines in CASP11 and CASP12.299674189/16/2024Associate
Baldassari M MichaelDA Phase I Clinical Trial of Targeted Intraoperative Molecular Imaging for Pulmonary Adenocarcinomas.293979329/16/2024Associate
Das D DebanandaEMechanism of Darunavir (DRV)'s High Genetic Barrier to HIV-1 Resistance: A Key V32I Substitution in Protease Rarely Occurs, but Once It Occurs, It Predisposes HIV-1 To Develop DRV Resistance.295110839/16/2024Associate
Das D DebanandaEGRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants.294635359/16/2024Associate
Kadasala NR Naveen ReddyDDry Etching with Nanoparticles: Formation of High Aspect-Ratio Pores and Channels Using Magnetic Gold Nanoclusters.291947939/16/2024Associate
Baldassari M MichaelAIdentification of a Folate Receptor-Targeted Near-Infrared Molecular Contrast Agent to Localize Pulmonary Adenocarcinomas.292419709/16/2024Associate
Madasamy S ShanmugavelPDifferential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles.291557769/16/2024Associate
Kadasala NR Naveen ReddyDEco-friendly (green) synthesis of magnetically active gold nanoclusters.284587439/16/2024Associate
Das D DebanandaEDesign and Development of Highly Potent HIV-1 Protease Inhibitors with a Crown-Like Oxotricyclic Core as the P2-Ligand To Combat Multidrug-Resistant HIV Variants.284186529/16/2024Associate
Das D DebanandaEA novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency.290397369/16/2024Associate
Dassanayake M MaheshiDGibberellin Signaling Requires Chromatin Remodeler PICKLE to Promote Vegetative Growth and Phase Transitions.280578959/16/2024Associate
Ramdas B BHSyk kinase and Shp2 phosphatase inhibition cooperate to reduce FLT3-ITD-induced STAT5 activation and proliferation of acute myeloid leukemia.272567029/16/2024Associate
Kadasala NR Naveen ReddyDPolymer-iron oxide composite nanoparticles for EPR-independent drug delivery.273109169/16/2024Associate
Das D DebanandaEA Modified P1 Moiety Enhances In Vitro Antiviral Activity against Various Multidrug-Resistant HIV-1 Variants and In Vitro Central Nervous System Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413.276204839/16/2024Associate
Kadasala NR Naveen ReddyDTime-Resolved Proteomic Visualization of Dendrimer Cellular Entry and Trafficking.264259245/2/2023Associate
Thulasidas JS Jeya Shree Proteomics study on the effect of combined treatment of electrical pulses and tomato lipophilic extract in the downregulation of proliferating cell nuclear antigen in triple-negative breast cancer cell-1 10/27/2021Associate
Das SR Suprem R Experimental and modeling study of 1/f noise in multilayer MoS2 and MoSe2 field-effect transistors-1 8/24/2021Associate
Dasgupta S SantanuDGenomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition.258694426/22/2021Associate
Dasgupta S SantanuDDesigning a broad-spectrum integrative approach for cancer prevention and treatment.265904776/22/2021Associate
Das D DebanandaEC-5-Modified Tetrahydropyrano-Tetrahydofuran-Derived Protease Inhibitors (PIs) Exert Potent Inhibition of the Replication of HIV-1 Variants Highly Resistant to Various PIs, including Darunavir.265819956/22/2021Associate
Shukradas S ShwetaDComparative Gene Expression Analyses Identify Luminal and Basal Subtypes of Canine Invasive Urothelial Carcinoma That Mimic Patterns in Human Invasive Bladder Cancer.263521426/22/2021Associate
Kadasala NR Naveen ReddyPTrace detection of tetrabromobisphenol A by SERS with DMAP-modified magnetic gold nanoclusters.260608416/22/2021Associate
Dasi LP Lakshmi PDEmerging Trends in Heart Valve Engineering: Part IV. Computational Modeling and Experimental Studies.262245226/22/2021Associate
Das M Manisit High performance immunochromatographic assay combined with surface enhanced Raman spectroscopy-1  Associate
Kadasala NR Naveen Reddy Characterization of Asphaltene Deposits by Using Mass Spectrometry and Raman Spectroscopy-1  Associate